Abstract:BACKGROUND:A recent genome-wide association study (GWAS) identified 99 loci that contain genetic risk variants shared between asthma, hay fever, and eczema. Many more risk loci shared between these common allergic diseases remain to be discovered, which could point to new therapeutic opportunities. OBJECTIVE:We sought to identify novel risk loci shared between asthma, hay fever, and eczema by applying a gene-based test of association to results from a published GWAS that included data from 360,838 subjects. METHODS:We used approximate conditional analysis to adjust the results from the published GWAS for the effects of the top risk variants identified in that study. We then analyzed the adjusted GWAS results with the EUGENE gene-based approach, which combines evidence for association with disease risk across regulatory variants identified in different tissues. Novel gene-based associations were followed up in an independent sample of 233,898 subjects from the UK Biobank study. RESULTS:Of the 19,432 genes tested, 30 had a significant gene-based association at a Bonferroni-corrected P value of 2.5 × 10-6. Of these, 20 were also significantly associated (P < .05/30 = .0016) with disease risk in the replication sample, including 19 that were located in 11 loci not reported to contain allergy risk variants in previous GWASs. Among these were 9 genes with a known function that is directly relevant to allergic disease: FOSL2, VPRBP, IPCEF1, PRR5L, NCF4, APOBR, IL27, ATXN2L, and LAT. For 4 genes (eg, ATXN2L), a genetically determined decrease in gene expression was associated with decreased allergy risk, and therefore drugs that inhibit gene expression or function are predicted to ameliorate disease symptoms. The opposite directional effect was observed for 14 genes, including IL27, a cytokine known to suppress TH2 responses. CONCLUSION:Using a gene-based approach, we identified 11 risk loci for allergic disease that were not reported in previous GWASs. Functional studies that investigate the contribution of the 19 associated genes to the pathophysiology of allergic disease and assess their therapeutic potential are warranted.

Present status on the genetic studies of asthma

Common Genes Underlying Asthma and COPD? Genome-wide Analysis on the Dutch Hypothesis

Genomic Predictors of Asthma Phenotypes and Treatment Response

Lung Eqtls to Help Reveal the Molecular Underpinnings of Asthma.

Shared Genetic Origin of Asthma, Hay Fever and Eczema Elucidates Allergic Disease Biology.

17Q21 Locus Rs7216389 Polymorphism and Childhood Asthma Risk: a Meta-Analysis

Analyses of Associations Between Three Positionally Cloned Asthma Candidate Genes and Asthma or Asthma-Related Phenotypes in a Chinese Population

SNPs Identified by GWAS Affect Asthma Risk Through DNA Methylation and Expression of Cis-Genes in Nasal (airway) Epithelium

Advancement of Bronchial Asthma in Genetics Studies

17Q21 Loci Gene and Childhood Asthma

Eleven loci with new reproducible genetic associations with allergic disease risk.

Pharmacodynamic genome-wide association study identifies new responsive loci for glucocorticoid intervention in asthma

A genome-wide association study of asthma hospitalizations in adults

Genetic liability to asthma and risk of cardiovascular diseases: A Mendelian randomization study

Unspecified asthma, childhood-onset, and adult-onset asthma have different causal genes: a Mendelian randomization analysis

De novo identification of complex traits associated with asthma

Single-Nucleotide Polymorphisms in Genes Predisposing to Asthma in Children of Chinese Han Nationality

Single-nucleotide Polymorphisms in Genes Predisposing to Asthma in Children of Chinese Han Nationality.

Prioritization of candidate causal genes for asthma in susceptibility loci derived from UK Biobank

New Strategy on Study of Susceptible Genes of Asthma Based on the Theory of Systems Biology and Candidate Gene Approach

Advances in the Study of Susceptibility Genes to Bronchial Asthma in Children